For patients with predispositions to inflammatory responses, sustained elevation of IL‐6 may lead to dermal fibrosis and pathological remodeling, potentially resulting in clinical manifestations such as hypertrophic scarring or cutaneous sclerosis [6]. The gene discussed is IL6; the disease is fibrosis.